News | Proton Therapy | January 27, 2017

Orlando Health and Mevion Offer Advanced Diagnostic Image Guidance for Proton Therapy

Mevion integrates in-room CT imaging to its Verity Patient Positioning System for the Mevion S250 at UF Health Cancer Center - Orlando Health

Mevion S250 proton therapy system, UF Health Cancer Center - Orlando Health, Airo CT scanner, Veritiy Patient Positioning System, radiation therapy

January 27, 2017 — Mevion Medical Systems and UF Health Cancer Center - Orlando Health recently announced the first patient treatment on a Mevion S250 proton therapy system in conjunction with Airo, a mobile, diagnostic computed tomography (CT) scanner. The advanced 3D CT-based localization is integrated to Verity Patient Positioning System, a component of the Mevion S250 Series, and is based on high-precision stereotactic localization and tracking technology. This solution improves treatment accuracy and reduces patient positioning uncertainties.

Orlando Health has been a pioneer in the implementation of image-guided radiation therapy (IGRT). The Mevion S250 is the first compact proton therapy system to integrate an in-room CT scanner for high-precision positioning and adaptive treatment, according to the company. CT imaging provides superior, high-resolution images that can be used for both positioning and adaptive treatment.

Orlando Health treated its first patient using a Mevion S250 in April 2016, and in less than four months was treating more than 20 patients per day thanks to the system’s fast ramp-up time, high throughput rate and low operating costs. Additionally, the Mevion S250 Series is capable of treating a wide variety of complex cases in adult and pediatric patients. In Orlando, it has treated tumors of the central nervous system (CNS), head and neck, breast, spine and other sensitive locations.

“Proton therapy is the most advanced treatment in radiation therapy and has allowed us to significantly reduce harmful radiation to healthy tissue, which is especially important for cancers near sensitive, hard-to-reach locations, both in children and adults,” said Naren R. Ramakrishna, M.D., Ph.D., director of neurologic and pediatric radiation oncology at Orlando Health. “Integrating proton therapy within our cancer center has given us the ability to provide a comprehensive range of services, allowing us to keep our patients in our system to receive the best treatment possible. In-room diagnostic CT imaging for positioning and treatment adaptation allows us to provide the most accurate treatment localization with protons.”

“This is an advancement in how we can precisely position patients for proton therapy compared to conventional planar imaging methods,” explained Omar Zeidan, Ph.D., chief of proton therapy physics at Orlando Health. “This CT-based IGRT system offers superior stereotactic localization with submillimeter accuracy in addition to the capability for adaptive proton therapy.”

For more information: www.mevion.com

Related Content

IBA Gathers Experts on Flash Irradiation During ASTRO
News | Proton Therapy | September 17, 2019
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019...
Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Radiation Therapy | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of...
Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.

News | Quality Assurance (QA) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear...
Varian Unveils Ethos Solution for Adaptive Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | September 16, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian...
Long-term Hormone Therapy Increases Mortality Risk for Low-PSA Men After Prostate Surgery
News | Prostate Cancer | September 16, 2019
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer...
The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning

The Siemens Somatom Go.Sim computed tomography (CT) system for dedicated radiation therapy planning. Image courtesy of Siemens Healthineers.

News | Computed Tomography (CT) | September 15, 2019
Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the...
Isoray to Spotlight Cesium-131 Advances at ASTRO Annual Meeting
News | Brachytherapy Systems | September 13, 2019
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the...
Akesis Galaxy SRS System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | September 13, 2019
The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has...
Philips Showcases Integrated Radiation Oncology Portfolio at ASTRO 2019
News | Radiation Oncology | September 13, 2019
Philips will showcase its integrated radiation oncology portfolio at the American Society of Radiation Oncology (ASTRO...
RefleXion Highlights Novel Approach to Radiotherapy at ASTRO 2019

The RefleXion X1 Machine without the Gantry Cover. The patented technology incorporates PET imaging data, which enables tumors to continuously signal their location. Image courtesy of Reflexion Medical.

News | Radiation Therapy | September 12, 2019
Therapeutic oncology company RefleXion Medical announced it will showcase the RefleXion X1 Machine at the American...